Nome Químico: (E)-2-(dibutylamino)-1-(2,7-dichloro-9-(4-chlorobenzylidene)-9H-fluoren-4-yl)ethan-1-ol
Sorrisos: ClC1=CC=C(C=C1)/C=C2C3=C(C4=C/2C=C(Cl)C=C4)C(C(O)CN(CCCC)CCCC)=CC(Cl)=C3
Inchi: InChI=1/C15H10Cl2O/c16-10-1-2-12-8(4-10)3-9-5-11(17)6-13(15(9)12)14-7-18-14/h1-2,4-6,14H,3,7H2
Stability-indicating HPLC-DAD/UV-ESI/MS impurity profiling of the anti-malarial drug lumefantrine
Mathieu Verbeken1† , Sultan Suleman1,3† , Bram Baert1 , Elien Vangheluwe1 , Sylvia Van Dorpe1 , Christian Burvenich2 , Luc Duchateau2 , Frans H Jansen4 , Bart De Spiegeleer
Verbeken et al. Malaria Journal 2011, 10:51 Page 2 of 9
Analytical Method Development and Validation for Estimation of Lumifantrine in Pharmaceutical Dosage Forms by HPLC
Naveen S Kotur *1 ,Singaravel Sivasamy2 , S.Srinivasan
J. Pharm. Sci. & Res. Vol.4(1), 2012,1672-1675
A Modified Method for Determination of Lumefantrine in Human Plasma by HPLC-UV and Combination of Protein Precipitation and Solid-Phase Extraction: Application to a Pharmacokinetic Study
Liusheng Huang, Patricia S. Lizak, Anura L. Jayewardene, Florence Marzan, Ming-Na Tina Lee and Francesca T. Aweeka
Analytical Chemistry Insights 2010:5 15–23